Red blood cell depletion of allogeneic bone marrow using hetastarch

被引：0
|
作者：
Griggs, P. [1 ]
Bruns, C. [1 ]
Leemhuis, T. [1 ]
机构：
[1] Univ Cincinnati, Acad Hlth Ctr, Hoxworth Blood Ctr, Cincinnati, OH USA
来源：
TRANSFUSION | 2007年 / 47卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：60A / 60A
页数：1
相关论文
共 50 条
  • [31] INFECTIOUS COMPLICATIONS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH AND WITHOUT T-CELL DEPLETION OF DONOR MARROW
    SCHMEISER, T
    WIESNETH, M
    BUNJES, D
    ARNOLD, R
    HERTENSTEIN, B
    HEIT, W
    KURRLE, E
    [J]. INFECTION, 1989, 17 (03) : 124 - 130
  • [32] Effective T-cell depletion of allogeneic blood and marrow grafts, using a CD34+ cell selection device.
    Viret, F
    Chabannon, C
    Vey, N
    Stoppa, AM
    Faucher, C
    Novakovitch, G
    Oziel-Taieb, S
    Gastaut, JA
    Maraninchi, D
    Blaise, D
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S102 - S102
  • [33] USE OF BLOOD COMPONENTS CONTAINING RED-CELLS BY DONORS OF ALLOGENEIC BONE-MARROW
    THOMPSON, HW
    MCCULLOUGH, J
    [J]. TRANSFUSION, 1986, 26 (01) : 98 - 100
  • [34] Telomere shortening following allogeneic bone marrow transplantation and allogeneic peripheral blood stem cell transplantation
    Robertson, JD
    Russell, N
    Wynn, RF
    Robinson, SA
    Stainer, C
    Jackson, G
    Dougal, M
    Scarffe, JH
    Chopra, R
    Testa, NG
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 35 - 35
  • [35] Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE spectra cell separator before haematopoietic stem cell transplantation
    Guttridge, M. G.
    Sidders, C.
    Booth-Davey, E.
    Pamphilon, D.
    Watt, S. M.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (03) : 175 - 181
  • [36] Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation
    M G Guttridge
    C Sidders
    E Booth-Davey
    D Pamphilon
    S M Watt
    [J]. Bone Marrow Transplantation, 2006, 38 : 175 - 181
  • [37] DONOR-DERIVED RED-BLOOD-CELL ANTIBODIES AND IMMUNE HEMOLYSIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HOWS, J
    BEDDOW, K
    GORDONSMITH, E
    BRANCH, DR
    SPRUCE, W
    SNIECINSKI, I
    KRANCE, RA
    PETZ, LD
    [J]. BLOOD, 1986, 67 (01) : 177 - 181
  • [38] Red blood cell depletion in small-volume bone marrow processing using manipulation with third-party red blood cells: A comparison of the performance of the COBE spectra and the spectra Optia systems
    Sumii, Yuichi
    Fujii, Nobuharu
    Fujii, Keiko
    Kondo, Takumi
    Urata, Tomohiro
    Kimura, Maiko
    Washio, Kana
    Fujiwara, Hideaki
    Asada, Noboru
    Ennishi, Daisuke
    Nishimori, Hisakazu
    Matsuoka, Ken-ichi
    Otsuka, Fumio
    Maeda, Yoshinobu
    [J]. TRANSFUSION, 2022, 62 (09) : 1829 - 1838
  • [39] GVHD PROPHYLAXIS IN ALLOGENEIC BONE-MARROW TRANSPLANTATION USING T-CELL DEPLETION BY CAMPATH-I AND COMPLEMENT
    WIESNETH, M
    ARNOLD, R
    BUNJES, D
    HERTENSTEIN, B
    SCHMEISER, T
    HALE, G
    HEIMPEL, H
    HEIT, W
    [J]. LEUKEMIA RESEARCH, 1986, 10 (01) : 121 - 121
  • [40] Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice
    JD Down
    GR Westerhof
    A Boudewijn
    R Setroikromo
    RE Ploemacher
    [J]. Bone Marrow Transplantation, 1998, 21 : 327 - 330
12345